CXCL12 and neoplasm: Although inhibition of PDGFRα reduces Sdf1 expression, no significant alterations in tumor cell proliferation or tumor growth were observed following pharmacological or genetic inhibition of PDGFRα in PD/S-SCCs [11], in agreement with that described after SDF-1 knocking-down.